Dietary supplements, plant alkaloids (local classification)
ATC code: A07AA-BERBERINE (Berberine – local code)
Brand names
Berberine Now Foods, Thorne Berberine, Solgar Berberine Root Extract, Doctor's Best Berberine
Berberine is an isoquinoline alkaloid found in barberry root (Berberis), goldenseal (Hydrastis canadensis), and Chinese goldthread (Coptis chinensis). It activates AMP-dependent protein kinase (AMPK), which explains its hypoglycaemic and lipid-lowering effects. Oral bioavailability is low (around 1%). Registered medicinal use exists only in China (bacterial diarrhoea). In Russia and Western countries, berberine is sold as a dietary supplement.
The drug is promoted for these uses outside international guidelines. Each entry below is analyzed against AEMPS, FDA, EMA, Cochrane and major RCTs.
Not recommended
Berberine is a plant alkaloid sold as a supplement to lower blood sugar in type 2 diabetes. Its benefit for this use has not been convincingly shown – there is no solid evidence behind the claim. Blood sugar in type 2 diabetes is reliably managed with changes to diet and physical activity, and where needed with medicines a doctor prescribes, such as metformin.
Not recommended
Berberine is a plant alkaloid sold as a supplement for weight loss and blood sugar control. Studies have not shown convincing benefit for losing weight at this use, and the evidence base for it is lacking. Sustained weight loss comes from a calorie deficit, regular physical activity and sleep, and for obesity – medical support and, when needed, medications with proven effect.
Not recommended
Berberine is an alkaloid found in barberry bark, goldenseal, and coptis. In biohacker protocols, berberine is positioned as a geroprotector via AMPK activation and calorie-restriction mimicry. Clinical studies in humans are few: meta-analyses in type 2 diabetes show modest reduction (0.5-1%) and weight reduction comparable to metformin in small samples. For healthy adults or life extension, no compelling evidence base exists; international anti-aging guidelines do not include berberine. The supplement causes GI disturbances (nausea, diarrhea, cramps), potential hepatotoxicity in susceptible people, and drug interactions (a strong CYP3A4 and P-gp inhibitor, raising blood levels of many drugs). If berberine was recommended for longevity, consider seeking a second opinion.
Not recommended
For prediabetes, berberine is marketed as a way to «avoid progression to type 2 diabetes». RCTs lasting over 2 years with diabetes conversion endpoints in prediabetic adults are unavailable. In and guidelines, the only pharmacological agent with proven effect in prediabetes is metformin for high-risk patients. Berberine is absent from these guidelines.
Opens the checker prefilled with this drug. Pick the second one from your regimen.
Contraindicated in pregnancy: berberine displaces bilirubin from albumin binding and can precipitate neonatal kernicterus.
Contraindicated during breastfeeding for the same mechanism.
Reference information, not a clinical decision. Discuss feeding pauses or changes with your physician or an IBCLC.
Berberine is evaluated for the following indications with varying evidence strength: Type 2 diabetes mellitus (evidence tier D), Weight loss (evidence tier D), Prediabetes (evidence tier F). See the full indication matrix with dosing and citations above on this page.
Common side effects of Berberine (≥ 1 in 100): GI discomfort, diarrhoea, constipation, Nausea, Headache, Hypoglycaemia when combined with other glucose-lowering drugs. See the Safety section for uncommon and serious reactions.
FDA category N. Contraindicated in pregnancy: berberine displaces bilirubin from albumin binding and can precipitate neonatal kernicterus.
Contraindicated during breastfeeding for the same mechanism.
Berberine is contraindicated in: Pregnancy (risk of kernicterus in the newborn if taken near term); Breastfeeding; Age under 18; Neonatal jaundice (G6PD deficiency, kernicterus); Concurrent warfarin, ciclosporin, tacrolimus, or high-dose statins. Full list in the Safety section.